NEW YORK (GenomeWeb News) – ChanTest today said that it has acquired Applied Cell Sciences, a Rockville, Md.-based contract research organization specializing in G-protein coupled receptors.

Cleveland-based ChanTest provides ion channel testing services and validated cell lines. The privately held firm said that it would maintain both sites and ACS' Founder and CEO Jesse Baumgold would join the company as vice president of business development and product strategy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.